1.Abraham NG, Lin JH, Schwartzman ML, Levere RD, Shibahara S(1988)The physiological significance of heme oxygenase. Int J Biochem 20: 543-58.
2.Aoam J (1994) Multiple elements within the 5′distal enhancer of the mouse heme oxygenase-1 gene mediate induction by heavy metals. J Biol Chem 69:25049-56.
3.Lavrovsky Y (1993) Novel regulatory sites of the human heme oxygenase-1 promoter region. Biochem Biophys Res Commun 96:336-41.
4.McCoubrey WK, Ewing JF, Maines MD (1992) Human heme oxygenase-2: characterization and expression of a full-length cDNA and evidence suggesting that the two HO-2 transcripts may differ by choice of polyadenylation signal. Arch Biochem Biophys 295: 13-20.
5.Doré S, Takahashi M, Ferris CD, Hester LD, Guastella D, Snyder SH (1999) Bilirubin formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci USA 96:2445–2450.
6.Hayashi S, Omata Y, Sakamoto H, Higashimoto Y, Hara T, Sagara Y, Noguchi M (2004) Characterization of rat heme oxygenase-3 gene: implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene 336:241–250.
7.Ryter SW, Alam J, Choi AMK(2006) Heme Oxygenase-1/Carbon Monoxide:From Basic Science to Therapeutic Applications. Physiol Rev 86: 583–650.
8.Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN (1987)Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043–1045.
9.Eisenstein RS, Garcia-Mayol D, Pettingell W, Munro HN (1991) Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc Natl Acad Sci USA 88: 688-692.
10.Berberat PO, Katori M, Kaczmarek E, Anselmo D, Lassman C, Ke B, Shen X, Busuttil RW, Yamashita K, Csizmadia E, Tyagi S, Otterbein LE, Brouard S, Tobiasch E, Bach FH, Kupiec-Weglinski JW, Soares MP (2003) Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J 17: 1724–1726.
11.Alam J, Shibahara S, Smith A (1989) Transcriptional activation of the heme oxygenase gene by heme and cadmium in mouse hepatoma cells. J Biol Chem 264:6371–6375.
12.Foresti R, Sarathchandra P, Clark JE, Green CJ, Motterlini R (1999) Peroxynitrite induces heme oxygenase-1 in vascular endothelia to apoptosis. Biochem J 339: 729–736.
13.Chen JC, Huang KC, Lin WW (2006) HMG-CoA reductase inhibitors upregulate heme oxygenase-1 expresssion in marine RAW 264.7 macrophages via ERK, p38MAPK and protein kinase G pathways. Cell Signal 18:32-39.
14.Zhang XC, Shan PY, Jiang DH, Noble PW, Abraham NG, Kappas A, Lee PJ (2004) Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J Biol Chem 279: 10677-10684.
15.Ke B, Shen XD, Gao F, Qiao B, Ji H, Busuttil RW, Volk HD, Kupiec-Weglinski JW (2009) Small Interfering RNA Targeting Heme Oxygenase-1 (HO-1) Reinforces Liver Apoptosis Induced by Ischemia-Reperfusion Injury in Mice: HO-1 Is Necessary for Cytoprotection. Hum Gene Ther 20:1133–1142.
16.Soares MP, Lin Y, Anrather J, Csizmadia E, Takigami K, Sato K, Grey ST, Colvin RB, Choi AM, Poss KD, Bach FH (1998) Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 4:1073–1077.
17.GoodmanmAI, Choudhury M, Silva JL, Schwartzman ML, Abraham NG (1997) Overexpression of the heme oxygenase gene in renal cell carcinoma. Proc Soc Exp Biol Med 214:54–61.
18.Berberat PO, Dambrauskas Z, Gulbinas A, Giese T, Giese N, Künzli B, Autschbach F, Meuer S, Büchler MW, Friess H (2005) Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res 11:3790–3798.
19.Torisu-Itakura H, Furue M, Kuwano M, Ono M (2000) Co-expression of thymidine phosphorylase and heme oxygenase-1 in macrophages in human malignant vertical growth melanomas. Jpn J Cancer Res 91:906–910.
20.Tsuji MH, Yanagawa T, Iwasa S, Tabuchi K, Onizawa K, Bannai S, Toyooka H, Yoshida H (1999) Heme oxygenase-1 expression in oral squamous cell carcinoma as involved in lymph node metastasis. Cancer Lett 138:53–59.
21.Sunamura M, Duda DG, Ghattas MH, Lozonschi L, Motoi F, Yamauchi J, Matsuno S, Shibahara S, Abraham NG (2003) Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis 6:15–24.
22.潘柏中(2003)糖尿病诊断和治疗的检验项目评价.中华医学杂志 83:169-171.
23.Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J (2000)Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 26:163–176.
24.Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1–9.
25.Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599–622.
26.Song FF, Qi XY, Chen WJ, Jia WB, Yao P, Nussler AK, Sun XF, Liu LG (2007) Effect of Momordica grosvenori on oxidative stress pathways in renal mitochondria of normal and alloxan-induced diabetic mice. Involvement of heme oxygenase-1. Eur J Nutr 46:61–69.
27.Hirai H, Kubo H, Yamaya M, Nakayama K, Numasaki M, Kobayashi S, Suzuki S, Shibahara S, Sasaki H (2000) Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 66:187– 195.
28.Ono K, Mannami T, Iwai N (2003) Association of a promoter variant of the haem oxygenase-1 gene with hypertension in women. J Hypertens 21:1497– 1503.
29.Ono K, Goto Y, Takagi S, Baba S, Tago N, Nonogi H, Iwai N (2004) A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese. Atherosclerosis 173:313– 317.
30.Kimpara T, Takeda A, Watanabe K, Itoyama Y, Ikawa S, Watanabe M, Arai H, Sasaki H, Higuchi S, Okita N, Takase S, Saito H, Takahashi K, Shibahara S (1997) Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet 100:145–147.
31.Chen YH, Chau LY, Lin MW, Chen LC, Yo MH, Chen JW, Lin SJ (2004) Heme oxygenase-1 promoter microsatellite polymorphism is associated with angiographic restenosis after coronary stenting. Eur Heart J 25:39–47.
32.Baan C, Peeters A, Lemos F, Uitterlinden A, Doxiadis I, Claas F, Ijzermans J, Roodnat J, Weimar W (2004) Fundamental role for HO-1 in the self protection of renal allografts. Am J Transplant 4:811–818.
33.Schillinger M, Exner M, Minar E, Mlekusch W, Müllner M, Mannhalter C, Bach FH, Wagner O (2004) Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor. J Am Coll Cardiol 43:950– 957.
34.Exner M, Böhmig GA, Schillinger M, Regele H, Watschinger B, Hörl WH, Raith M, Mannhalter C, Wagner OF (2004) Donor heme oxygenase-1 genotype is associated with renalallograft function. Transplantation 77:538– 542.
35.Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, Charng MJ, Wu TC, Chen LC, Ding YA, Pan WH, Jou YS, Chau LY (2002)Microsatellite polymorphism in promoter of heme oxygenase gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111:1 – 8.
36.Hirai H, Kubo H, Yamaya M, Nakayama K, Numasaki M, Kobayashi S, Suzuki S, Shibahara S, Sasaki H (2003) Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines. Blood 102:1619– 1624.
37.Goodman AI, Choudhury M, da Silva JL, Schwartzman ML, Abraham NG (1997) Overexpression of the heme oxygenase gene in renal cell carcinoma. Proc Soc Exp Biol Med 214:54–61.
38.支修益(2009)我国肺癌流行病学现状分析.中国处方药 (2):56-57.
39.Wynder EI, Hoffmann D (1994) Smoking and lung cancer scientific challenges and opportunities. Cancer Res 54:5284-5295.
40.Zhu W, Zhou QH (2005) Research progress of etiology and genetic susceptibility of lung cancer. Zhong guo Fei Ai Za Zhi 8:385-389.
41.苏婉,徐振晔(2010)从基因多态性及体质学说探讨肺癌的中医证候. 中西医结合学 1:15-19.
42.Favatier F, Polla BS (2001) Obacco-smoke-inducible human haem oxygenase-1 gene expression: role of distinct transcription factors and reactive oxygen intermediates. Biochem J 353:475-482.
43.Silverman EK, Chapman HA, Drazen JM, Weiss ST, Rosner B, Campbell EJ, O'Donnell WJ, Reilly JJ, Ginns L, Mentzer S, Wain J, Speizer FE (1998) Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease: risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 157:1770– 1778.
44.Otterbein LE, Kolls JK, Mantell LL, Cook JL, Alam J, Choi AMK (1999) Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 103:1047– 1054.
45.He JQ, Ruan J, Connett JE, Anthonisen NR, Paré PD, Sandford AJ (2002) Antioxidant gene polymorphisms and susceptibility to rapid decline in lung function in smokers. Am J Respir Crit Care Med 166:323–328.
46.Kikuchi A, Yamaya M, Suzuki S, Yasuda H, Kubo H, Nakayama K, Handa M, Sasaki T, Shibahara S, Sekizawa K, Sasaki H(2005)Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism. Hum Genet 116: 354–360.
47.World Health Organization. Expert committee on malaria: 20th report. [accessed 2010].
48.Pamplona A, Ferreira A, Balla J, Jeney V, Balla G, Epiphanio S, Chora A, Rodrigues CD, Gregoire IP, Cunha-Rodrigues M, Portugal S, Soares MP, Mota MM (2007) Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat Med 13:703–710.
49.Schluesener HJ, Kremsner PG, Meyermann R(2001) Heme oxygenase-1 in lesions of human cerebral malaria. Acta Neuropathol 101:65–68.
50.Medana IM, Mai NT, Day NP , Bethell D, Phu NH, Farrar J, Esiri MM, White NJ, Turner GD (2001) Cellular stress and injury responses in the brains of adult Vietnamese patients with fatal Plasmodium falciparum malaria. Neuropathol Appl Neurobiol 27:421–433.
51.Clark IA, Awburn MM, Harper CG, Liomba NG, Molyneux ME (2003) Induction of HO-1 in tissue macrophages and monocytes in fatal falciparum malaria and sepsis. Malar J 2:41.
52.Lanaro C, Franco-Penteado CF, Albuqueque DM, Saad ST, Conran N, Costa FF(2009)Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy. J Leukoc Biol 85:235–242.
53.Fowkes FJ, Allen SJ, Allen A, Alpers MP, Weatherall DJ, Day KP(2005)Both heterozygous and homozygous thalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya. Blood 106:368–371.
54.Allen SJ, O'Donnell A, Alexander ND, Alpers MP, Peto TE, Clegg JB, Weatherall DJ (1997) a+-Thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci USA 94:14736–14741.
55.May J, Evans JA, Timmann C, Ehmen C, Busch W, Thye T, Agbenyega T, Horstmann RD(2007)Hemoglobin variants and disease manifestations in severe falciparum malaria. JAMA 297:2220–2226.
56.Mockenhaupt FP, Ehrhardt S, Gellert S, Otchwemah RN, Dietz E, Anemana SD, Bienzle U(2004) a+-Thalassemia protects African children from severe malaria. Blood 104:2003–2006.
57.Veenemans J, Andang'o PE, Mbugi EV, Kraaijenhagen RJ, Mwaniki DL, Mockenhaupt FP, Roewer S, Olomi RM, Shao JF, van-der-Meer JW,Savelkoul HF, Verhoef H (2008) a+-Thalassemia protects against anemia associated with asymptomatic malaria: evidence from communitybased surveys in Tanzania and Kenya. J Infect Dis 198:401–408.
58.Ferreira A, Balla J, Jeney V, Balla G, Soares MP (2008) A central role for free heme in the pathogenesis of severe malaria: the missing link? J Mol Med 86:1097–1111.
59.Conran N, Costa FF (2009) Hemoglobin disorders and endothelial cell interactions.Clin Biochem 42:1824–1838.
60.Lavrovsky Y, Chatterjee B, Clark RA, Roy AK (2000) Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol 35:521–532.
61.Garcia-Santos D, Chies JAB (2010) HO-1 polymorphism as a genetic determinant behind the malaria resistance afforded by haemolytic disorders. Med Hypotheses 74: 807–813.
62.Takeda M, Kikuchi M, Ubalee R, Na-Bangchang K, Ruangweerayut R, Shibahara S, Imai S, Hirayama K (2005) Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to cerebral malaria in Myanmar. Jpn J Infect Dis 58:268–271.
63.Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K, Aizawa T, Ishizaka N, Nagai R (2002) Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 22:1680– 1685.
64.Endler G, Exner M, Schillinger M, Marculescu R, Sunder-Plassmann R, Raith M, Jordanova N, Wojta J, Mannhalter C, Wagner OF, Huber K (2004) A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease. Thromb Haemostasis 91:155– 161.
65.Orford JL, Selwyn AP, Ganz P, Popma JJ, Rogers C(2000)The comparative pathobiology of atherosclerosis and restenosis. Am J Cardiol 86:6H– 11H.
66.Tulis DA, Durante W, Peyton KJ, Evans AJ, Schafer AI (2001) Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. Atherosclerosis 155:113– 122.
67.Maines MD (1988) Heme oxygenase: function, multiplicity, regulatory mechanisms and clinical application. FASEB J 2:2557– 2568.
68.Schillinger M, Exner M, Mlekusch W, W Mlekusch, M Müllner, MSc(Epi), C Mannhalter, FH Bach, O Wagner(2002)Heme oxygenase-1 genotype is a vascular anti-inflammatory factor following balloon angioplasty. J Endovasc Ther 9:385–394.
69.Exner M, Schillinger M, Minar E, Mlekusch W, Schlerka G, Haumer M, Mannhalter C, Wagner O (2001) Heme oxygenase-1 promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther 8:433– 440.
70.Schillinger M, Exner M, Mlekusch W, Domanovits H, Huber K, Mannhalter C, Wagner O, Minar E(2002)Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm. Thromb Res 106:131–136.
71.Kanai M, Tanabe S, Okada M, Suzuki H, Katsuura M, Akiba T, Hayasaka K (2003) Polymorphisms of heme oxygenase-1 and bilirubin UDP-glucuronyltransferase genes are not associated with Kawasaki disease susceptibility. Tohoku J Exp Med 200:155– 159.
72.Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesisof type 2 diabetes. Endocr Rev 23:599–622.
73.Deshane J, Wright M, Agarwal A (2005) Heme oxygenase-1 expression in disease states. Acta Biochim Pol 52:273–284.
74.Song Ff, Li XY, Zhang MX, Yao P, Yang NH, Sun XF, Hu FB, Liu LG(2009)Association Between Heme Oxygenase-1 Gene Promoter Polymorphisms and Type 2 Diabetes in a Chinese Population. Am J Epidemiol 170:747–756.
75.Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, Charng MJ, Wu TC, Chen LC, Ding YA, Pan WH, Jou YS, Chau LY (2002) Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111:1–8.
76.Salahudeen AA, Jenkins JK, Huang H, Ndebele K, Salahudeen AK (2001) Overexpression of heme oxygenase protects renal tubular cells against cold storage injury: studies using hemin induction and HO-1 gene transfer. Transplantation 72: 1498–1504.
77.Pileggi A, Molano RD, Berney T, Cattan P, Vizzardelli C, Oliver R, Fraker C, Ricordi C, Pastori RL, Bach FH, Inverardi L(2001)Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50:1983–1991.
78.Sato K, Balla J, Otterbein L, Smith RN, Brouard S, Lin Y, Csizmadia E, Sevigny J, Robson SC, Vercellotti G, Choi AM, Bach FH, Soares MP (2001) Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 166:4185– 4194.
79.Lin Y, Soares MP, Sato K, Takigami K, Csizmadia E, Smith N, Bach FH (1999) Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts. J Immunol 163:2850–2857.
80.Hancock WW, Buelow R, Sayegh MH, Turka LA (1998) Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 4:1392–1396.
81.Amersi F, Shen XD, Anselmo D, Melinek J, Iyer S, Southard DJ, Katori M, Volk HD, Busuttil RW, Buelow R, Kupiec-Weglinski JW (2002) Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology 35:815– 823.
82.Katori M, Buelow R, Ke B, Ma J, Coito AJ, Iyer S, Southard D, Busuttil RW, Kupiec-Weglinski JW (2002) Heme oxygenase-1 overexpression protects rat hearts from cold ischemia/reperfusion injury via an antiapoptotic pathway. Transplantation 73:287–292.
83.Nath KA(1999)Heme oxygenase-1: a redoubtable response that limits reperfusion injury in the transplanted adipose liver. J Clin Invest 104:1485–1486.
84.Chang KW, Lee TC, Yeh WI, Chung MY, Liu CJ, Chi LY, Lin SC(2004) Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers. Br J Cancer 91:1551–1555.
85.Kikuchi A, Yamaya M, Suzuki S (2005) Association of susceptibility to the development of lung aden carcinoma with the heme oxygenase-1 gene promoter polymorphism. Hum Genet 116: 354–360.
86.Okamoto I, Krögler J, Endler G, Kaufmann S, Mustafa S, Exner M, Mannhalter C, Wagner O, Pehamberger H (2006) A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with risk for melanoma. Int J Cancer 119:1312–1315.
87.Tomohiro S, Mounia M, Masayuki T (2008) Increased risk of gastric cancer in Japanese subjects is associated with microsatellite polymorphisms in the heme oxygenase-1 and the inducible nitric oxide synthase gene promoters. Cancer Lett 269:78–84.
88.Lo SS, Lin SC, Wu CW, Chen JH, Yeh WI, Chung MY, Lui WY (2006) Heme Oxygenase-1 Gene Promoter Polymorphism is Associated with Risk of Gastric Adenocarcinoma and Lymphovascular Tumor Invasion. Ann Surg Oncol 14:2250–2256.
89.Budhi A, Hiyama K, Isobe T, Oshima Y, Hara H, Maeda H, Kohno N (2003) Genetic susceptibility for emphysematous changes of the lung in Japanese. Int J Mol Med 11:321–329.
90.Exner M, Minar E, Wagner O, Schillinger M (2004) The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 37:1097–1104.
91.Gulesserian T, Wenzel C, Endler G, Sunder-Plassmann R, Marsik C, Mannhalter C, Iordanova N, Gyöngyösi M, Wojta J, Mustafa S, Wagner O, Huber K (2005) Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variant. Clin Chem 51:1661–1665.